Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) FCF Margin (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of FCF Margin data on record, last reported at 15.41% in Q4 2025.

  • For Q4 2025, FCF Margin rose 943.0% year-over-year to 15.41%; the TTM value through Dec 2025 reached 4.34%, down 520.0%, while the annual FY2025 figure was 4.34%, 520.0% down from the prior year.
  • FCF Margin reached 15.41% in Q4 2025 per ORGO's latest filing, up from 0.56% in the prior quarter.
  • Across five years, FCF Margin topped out at 31.43% in Q4 2021 and bottomed at 39.57% in Q2 2025.
  • Average FCF Margin over 5 years is 0.07%, with a median of 1.03% recorded in 2023.
  • Peak YoY movement for FCF Margin: surged 3325bps in 2021, then tumbled -4066bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 31.43% in 2021, then plummeted by -108bps to 2.47% in 2022, then soared by 396bps to 7.32% in 2023, then fell by -18bps to 5.98% in 2024, then soared by 158bps to 15.41% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 15.41% in Q4 2025, 0.56% in Q3 2025, and 39.57% in Q2 2025.